Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator XenaLives, 123tom
Search This Board:
Last Post: 12/1/2014 6:56:13 PM - Followers: 36 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GALT
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for GALT
GALT News: Statement of Changes in Beneficial Ownership (4) 12/17/2014 04:37:25 PM
GALT News: Current Report Filing (8-k) 12/12/2014 05:01:58 PM
GALT News: Statement of Changes in Beneficial Ownership (4) 11/19/2014 04:51:26 PM
GALT News: Current Report Filing (8-k) 11/10/2014 08:07:26 AM
GALT News: Current Report Filing (8-k) 11/10/2014 08:04:08 AM
PostSubject
#1534  Sticky Note This is my final post on any public biotech2010 09/24/14 04:59:33 PM
#1725   I dont know if the chart is worth 123tom 12/01/14 06:56:13 PM
#1724   I know we're supposed to be funded well Darwinian 12/01/14 10:12:15 AM
#1723   bloody monday... oldsport 12/01/14 09:34:20 AM
#1722   bloody black friday... oldsport 11/28/14 04:36:16 PM
#1719   my new theory on why pps has gone oldsport 11/24/14 09:27:45 AM
#1718   It's possible that a teleconference with the complete thefamilyman 11/21/14 11:40:53 PM
#1717   this past week is just incomprehensible... oldsport 11/21/14 11:18:33 PM
#1716   Thanks for your informed reply. Darwinian 11/21/14 10:22:34 PM
#1715   FM: I'm in agreement with your assessment. Do Darwinian 11/21/14 04:12:12 PM
#1714   thanks for that eval update family man. 123tom 11/21/14 03:24:48 PM
#1713   My best guess... Two things: thefamilyman 11/21/14 02:53:59 PM
#1712   Yesterday GALT collapses down to 4 dollars. 123tom 11/21/14 01:22:43 PM
#1710   Thanks! JCHF thefamilyman 11/20/14 09:52:45 PM
#1709   JCHF The acronym for the Journal of American Seagrass 11/20/14 09:33:26 PM
#1708   Excellent and thx for posting. Question; do they possibly davidc2 11/20/14 05:30:11 PM
#1707   lots of day traders looking here today at oldsport 11/20/14 02:49:58 PM
#1706   I've noticed (rather consistently) that the posters who pugdaddy 11/20/14 02:02:35 PM
#1705   i think galt is the game where the oldsport 11/20/14 09:50:35 AM
#1704   been averaging down... this has to stop... oldsport 11/20/14 09:22:25 AM
#1703   It is interesting and a positive sign in Darwinian 11/20/14 08:54:39 AM
#1702   journal of card hf ? oldsport 11/19/14 11:12:36 PM
#1701   It says something about Author Affiliations so could thefamilyman 11/19/14 10:49:57 PM
#1700   juvie congestive heart failure? oldsport 11/19/14 10:48:11 PM
#1699   that just opens up a huge potential new oldsport 11/19/14 10:46:56 PM
#1698   Independent confirmation of Galactin 3 inhibition's positive impact thefamilyman 11/19/14 10:40:24 PM
#1697   Now this could be very interesting for GALT Seagrass 11/19/14 10:06:33 PM
#1696   epic battle of the bulls vs the bear... oldsport 11/18/14 03:47:08 PM
#1695   this thing is gonna bounce w a vengeance... oldsport 11/18/14 12:14:10 PM
#1694   I am glad that they are targeting cirrhosis thefamilyman 11/17/14 03:06:14 PM
#1693   gonna have a nice bounce soon... oldsport 11/17/14 11:23:13 AM
#1692   Darwinian, I agree w/you also. In the pugdaddy 11/17/14 06:27:07 AM
#1691   correct u r sir... melanoma phase1 should be oldsport 11/16/14 08:35:59 PM
#1690   I've been thinking over the recent release of Darwinian 11/16/14 08:23:31 PM
#1689   Watching the technical chart,its very hard to see 123tom 11/13/14 01:53:42 PM
#1688   You're welcome Tom. So basically you see Tesla1 11/13/14 01:40:39 PM
#1687   I believe that the model X is being Tesla1 11/13/14 01:39:22 PM
#1686   i just put down 5k for model x oldsport 11/13/14 01:33:41 PM
#1685   Thanks Tesla,I shall , and I appreciate 123tom 11/13/14 01:30:22 PM
#1684   Tom: My two cents...The main other drug Tesla1 11/13/14 01:10:31 PM
#1683   Here it is: Darwinian 11/12/14 10:17:55 PM
#1682   Tesla, thanks very much for your thoughts... I 123tom 11/12/14 09:35:59 PM
#1681   This link points to a MLV's rating of Darwinian 11/12/14 09:23:03 PM
#1680   Tom: Trim away, don't let me sway you Tesla1 11/12/14 08:53:30 PM
#1679   $GALT MLV Reiterates Buy On Galectin Therapeutics On maytepper 11/12/14 08:50:26 PM
#1678   so i can get back in... oldsport 11/12/14 06:37:08 PM
#1677   why jmh0602 11/12/14 06:17:07 PM
#1676   i would dump all my shares now... get oldsport 11/12/14 05:15:40 PM
#1675   I may have to agree with you 123tom 11/12/14 05:00:02 PM
#1674   unfortunately the i*pt recent pps drop did not oldsport 11/11/14 11:07:13 PM
#1673   Unfortunate but most likely true, I sure GALT DirectionalDriller 11/11/14 10:21:14 PM
PostSubject